Related by context. All words. (Click for frequent words.) 69 neratinib 68 proteasome inhibitor 67 Xanafide 67 MEK inhibitors 67 MAGE A3 ASCI 67 JAK inhibitor 67 orally bioavailable 67 rNAPc2 66 ENMD # 66 alvespimycin 66 Carfilzomib 66 targeting CD# 66 Tyrima 66 antiproliferative effects 66 favorable pharmacokinetic profile 66 preclinically 66 otelixizumab 66 vascular disrupting agents 66 XmAb# 66 HCV protease inhibitors 66 histone deacetylase inhibitor 65 Epothilones 65 HSP# inhibitor 65 CCX# 65 Sphingomab 65 proteasome inhibitors 65 Bortezomib 65 selective inhibition 65 depsipeptide 65 JAK inhibitors 65 EGFR tyrosine kinase inhibitors 65 JAK2 inhibitor 65 Onconase 65 mertansine 65 HGS ETR2 65 custirsen sodium 65 sodium glucose cotransporter 65 Smac mimetics 65 epigenetic therapies 65 PXD# 65 fosbretabulin 65 investigational humanized monoclonal antibody 64 pertuzumab 64 CYC# 64 5alpha reductase 64 #D#C# 64 K ras mutations 64 oral prodrug 64 demethylating agents 64 ganetespib 64 Perifosine 64 elotuzumab 64 Virulizin ® 64 HQK 64 JAK3 64 Hedgehog inhibitor 64 liposomal formulation 64 Campath ® 64 XL# XL# XL# XL# 64 Archexin 64 small molecule activators 64 histone deacetylase HDAC 64 immunomodulatory 64 interferon lambda 64 orally administered inhibitor 64 PrevOnco 64 Exelixis compounds 64 Ceflatonin 63 Gleevec resistant 63 Symadex 63 receptor tyrosine kinase inhibitor 63 cytoprotective 63 HuLuc# 63 OncoVEX 63 Pimavanserin 63 EGFR inhibitors 63 ARIKACE ™ 63 novel anticancer 63 HGS ETR1 63 PI3K/mTOR 63 endogenous ligands 63 FLT3 63 anticancer therapies 63 therapeutic monoclonal antibody 63 kinase inhibition 63 Akt inhibitor 63 BAY #-# 63 Antiangiogenic 63 YONDELIS 63 MYDICAR ® 63 Azixa 63 OXi# 63 cytotoxic agents 63 Trp p8 63 Seliciclib 63 bevacizumab Avastin ® 63 PS# [001] 63 XL# XL# 63 INCB# [001] 63 BRAF inhibitor 63 Vidofludimus 63 antiangiogenic 63 TRISENOX ® 63 pharmacokinetic interactions 63 Anticalins R 63 pralatrexate 63 GMX# 63 Dapagliflozin 63 PDE4 inhibitor 63 cytostatic 63 radiation sensitizer 63 epothilones 63 immunomodulating 63 Squalamine 63 dacetuzumab 63 VEGF inhibitors 63 systemically administered 63 antisense drug 63 varespladib 63 mTOR inhibitors 63 protein kinase inhibitor 63 non nucleoside 63 ruxolitinib 63 interferon IFN 63 CYT# potent vascular disrupting 63 CA4P 62 Panzem R 62 Tarvacin 62 IL# PE#QQR 62 anticancer agents 62 Telintra 62 NEUGENE 62 personalized immunotherapy 62 HSP# inhibitors 62 Allovectin 7 ® 62 TELCYTA 62 fluoropyrimidine 62 UPLYSO 62 cilengitide 62 MGCD# [001] 62 ART# 62 siRNAs targeting 62 siRNA therapeutic 62 Smac mimetic 62 immune modulating 62 entinostat 62 PEG SN# 62 Pathway Inhibitor 62 novel immunomodulatory 62 somatostatin analogue 62 Tarceva TM 62 isotype 62 anticoagulant reversing agent 62 trastuzumab emtansine T DM1 62 anticancer compound 62 SERMs 62 tipifarnib 62 osteogenic 62 T#I [002] 62 Personalized Immunotherapy 62 Aplidin 62 sorafenib tablets 62 anti leukemic 62 VEGF receptor 62 Factor VIIa 62 IMC A# 62 Traficet EN 62 LY# [003] 62 antitumor 62 selective inhibitors 62 seliciclib 62 #ME# 62 inhibit EGFR 62 IMA# 62 vosaroxin 62 bioactive lipids 62 Panzem 62 BCR ABL inhibitors 62 Phase #b/#a clinical 62 OncoVEX GM CSF 62 PI3K/Akt pathway inhibitor 62 nucleoside analogues 62 A3 adenosine receptor 62 AEG# 62 Insegia 62 synthetic retinoid 62 anti amnesic 62 KRN# 62 Amrubicin 62 DOS# 62 novel peptide 62 CCR2 62 E#F# 62 PRT# 62 enzastaurin 62 molecularly targeted 62 RAV# 62 deacetylase inhibitors 62 TELINTRA 62 MyVax R 62 CD# monoclonal antibody 62 ZOLINZA 62 mTOR inhibition 62 lintuzumab 62 selective modulator 62 HCV replicon 62 metaglidasen 62 isoform selective 62 HER2 receptor 62 Maribavir 62 CD# antibody [001] 62 TLR8 62 tubulin inhibitor 62 MGd 62 epithelial tumors 62 Azedra 62 antimetabolite 62 EGFR HER2 62 Radezolid 62 Gemzar ® 62 Thiovir 62 Dasatinib 62 Proxinium TM 62 Reverset 62 RhuDex ® 62 PARP inhibitor 62 HuMax CD4 62 chemopreventive agent 61 Bezielle 61 phosphate S1P 61 bardoxolone 61 peptide antigens 61 anti fibrotic 61 epothilone 61 microtubule targeting 61 amrubicin 61 histone deacetylase HDAC inhibitor 61 Tß4 61 vascular disrupting agent 61 vemurafenib 61 Zolinza 61 GRNVAC1 61 Combidex 61 R roscovitine 61 selective antagonist 61 potency selectivity 61 cannabinor 61 erlotinib Tarceva ® 61 bosutinib 61 pharmacodynamic markers 61 vinca alkaloid 61 Triolex 61 thymalfasin 61 orally dosed 61 effector function 61 polymerase inhibitor 61 DXL# 61 mda 7 61 Enzastaurin 61 Adentri 61 BZL# 61 nucleoside analogs 61 sorafenib Nexavar 61 Elvitegravir 61 Panzem R NCD 61 Allovectin 7 R 61 myelofibrosis polycythemia vera 61 Cloretazine R 61 TriRima 61 breast cancer subtypes 61 pan HDAC inhibitor 61 tanespimycin 61 Granulocyte Colony Stimulating Factor 61 teriflunomide 61 CCR5 antagonist 61 elacytarabine 61 humanized anti 61 HCV protease 61 ON #.Na 61 XL# anticancer compounds 61 Tarvacin Anti Viral 61 alkylating agent 61 pomalidomide 61 PSN# [002] 61 riociguat 61 dasatinib Sprycel 61 Vilazodone 61 humanised monoclonal antibody 61 cediranib 61 Aviptadil 61 Cintredekin Besudotox 61 imatinib resistance 61 mutational status 61 OMP #M# 61 ALN TTR# 61 TOCOSOL Paclitaxel 61 pharmacodynamic properties 61 anti CD# antibodies 61 neurotrophic 61 OvaRex R 61 PNP inhibitor 61 talabostat 61 cMET 61 pro angiogenic 61 romidepsin 61 Cloretazine 61 selective androgen receptor modulator 61 selective adenosine 61 oral JAK1 61 obatoclax 61 NS5A 61 PI3K inhibitor 61 Panzem NCD 61 anticancer therapy 61 Bicifadine 61 ATL# [002] 61 TLR9 agonist 61 Akt activation 61 tyrosine kinase inhibitors 61 Tarvacin TM 61 EP #R 61 TACI Ig 61 phase IIb clinical 61 antithrombotic 61 multitargeted 61 oxidative stress inducer 61 ELACYT 61 Oral NKTR 61 trastuzumab Herceptin R 61 5 HT4 receptor 61 TBC# 61 hematological cancers 61 tyrosine kinase inhibitor 61 peptidomimetic 61 gemcitabine cisplatin 61 MOZOBIL 61 microtubule inhibitor 61 Aurora kinase 61 immune modulatory 61 selective kinase inhibitor 61 chemically modified siRNA 61 synthetic siRNA 61 plasma kallikrein inhibitor 61 trastuzumab DM1 T DM1 61 Maxy G# 61 virus HCV protease inhibitor 61 TLK# 61 cancer immunotherapies 61 GRN#L 61 refractory Hodgkin lymphoma 61 Pralatrexate 61 GSK# [001] 61 Fc fusion protein 61 Talabostat 61 TKM ApoB 60 Anticalin R 60 IAP inhibitors 60 GRN# 60 Targretin 60 enzyme inhibitor 60 posaconazole 60 myeloproliferative diseases 60 valopicitabine 60 anti CD3 60 TLR8 agonist 60 CYP #D# 60 refractory chronic lymphocytic 60 Nexavar ® 60 FGFR 60 OvaRex ® MAb 60 OHR/AVR# 60 YONDELIS R 60 THR beta agonist 60 DermaVir Patch 60 Phase #b/#a trial 60 S/GSK# 60 nonclinical studies 60 MAP# 60 preclinical efficacy 60 CBLC# 60 samalizumab 60 nucleotide analog 60 pharmacodynamic PD 60 immunomodulator 60 EGFR pathway 60 GPNMB 60 CDK inhibitors 60 bleomycin 60 VEGF inhibitor 60 huC# DM4 60 diagnostic biomarker 60 Fludara ® 60 EndoTAGTM 1 60 NV1FGF 60 highly selective inhibitor 60 humanized monoclonal antibodies 60 PANVAC VF 60 PSMA ADC 60 novel histone deacetylase 60 aflibercept 60 Solorel TM 60 delafloxacin 60 anticancer agent 60 eIF 4E 60 bortezomib Velcade 60 candidate deforolimus 60 AP# [003] 60 Arimoclomol 60 Zybrestat 60 mitochondrial toxicity 60 Panitumumab 60 Omacetaxine 60 Tesetaxel 60 calcineurin inhibitors 60 PDX pralatrexate 60 carbohydrate polymer 60 axitinib 60 sulodexide 60 CEQ# 60 HGS# 60 Hsp# Inhibitor 60 PDE#A 60 indibulin 60 immunostimulatory 60 potent anticancer 60 telaprevir VX 60 Pemetrexed 60 dasatinib Sprycel ® 60 Anticalin ® 60 tramiprosate 60 IRX 2 60 novel VDA molecule 60 Amplimexon 60 volociximab 60 JVRS 60 hypoxia activated prodrug 60 Cloretazine ® 60 CCR5 inhibitor 60 potent inhibitor 60 JAK1 60 Mipomersen 60 GW# [003] 60 XYOTAX TM 60 CB2 receptor 60 ALK inhibitor 60 gefitinib Iressa 60 HCD# [002] 60 TLR antagonists 60 G#DT 60 OvaRex 60 CR# vcMMAE 60 mTOR inhibitor 60 NF kB pathway 60 Ocrelizumab 60 receptor inhibitor 60 anticancer activity 60 imatinib Gleevec ® 60 humanized monoclonal antibody 60 favorable pharmacokinetic 60 insulin sensitizers 60 2 methoxyestradiol 60 small molecule tyrosine 60 Voreloxin 60 antitumoral 60 splice variants 60 AVE# 60 TOCOSOL Camptothecin 60 Solazed TM 60 Sym# 60 antiangiogenic therapy 60 darapladib 60 pain palliation 60 IAP inhibitor 60 IL# PE 60 decitabine 60 ATL/TV# 60 Valortim R 60 lumiliximab 60 HuMax EGFr 60 anti angiogenic agents 60 JAK2 60 reversible inhibitor 60 ZYBRESTAT fosbretabulin 60 antisense oligonucleotides 60 GRNCM1 60 IMC #B 60 chemokine receptor 60 maribavir 60 erythropoietic 60 fibrotic disease 60 SGLT2 60 M# rationally 60 Temsirolimus 60 Angiolix 60 Tesmilifene 60 apoptotic pathway 60 immunoregulatory 60 HDACi 60 peptibody 60 sd rxRNA 60 adecatumumab 60 SARMs 60 Leukine ® 60 CINTREDEKIN BESUDOTOX 60 trastuzumab Herceptin ® 60 immune stimulatory 60 EOquin 60 Chemophase 60 HoFH 60 ularitide 60 uric acid lowering 60 p# inhibitors 60 IL #E 60 IgG1 antibody 60 antitumor effect 60 GSK# [002] 60 SAR# [004] 60 MEK inhibitor 60 inhibit angiogenesis 60 atacicept 60 genotypic resistance 60 ixabepilone 60 oral ridaforolimus 60 Imprime PGG 60 retapamulin 60 Hsp# inhibitors 60 TYZEKA 60 AQ4N 60 CB1 antagonists 60 antisense oligonucleotide 60 antiangiogenic agent 60 RhuDex R 60 GLYX 60 FK# 60 Vorinostat 60 ZACTIMA 60 demonstrated antitumor activity 60 Tamibarotene 60 Estrogen Receptor 60 thymidylate synthase TS 60 Amigal 60 oral anticancer 60 panobinostat 60 menadione 60 cetuximab Erbitux R 60 Vidaza azacitidine 60 SinuNase 60 MTP inhibitor 60 xenograft models 60 LEP ETU 59 PRTX 59 GPCR targets 59 Hsp# inhibitor 59 therapeutic monoclonal antibodies 59 HepDirect prodrug 59 SIRT2 59 Trofex TM 59 SYN# 59 nanopharmaceutical 59 beta interferons 59 HCV polymerase inhibitors 59 Interferon alpha 59 gemcitabine Gemzar 59 PARP inhibitors 59 TRIOLEX HE# APOPTONE HE# 59 Marqibo TM 59 Neuradiab 59 GSK3B 59 histone deacetylases 59 Corgentin 59 pDCs 59 glioblastoma multiforme GBM 59 irreversible inhibitor 59 antisense inhibitors 59 myeloma cells 59 Romidepsin 59 non nucleoside HCV 59 immunomodulatory properties 59 Ampligen R 59 HepDirect 59 thalidomide Thalomid 59 Dacogen decitabine 59 Thalomid ® 59 Azedra ™ 59 Arsenic trioxide 59 hedgehog pathway 59 antibody MAb 59 SGLT 2 59 Omacetaxine mepesuccinate 59 soluble receptor 59 generation Hsp# inhibitor 59 polymerase inhibitors 59 superficial bladder cancer 59 c MYC 59 annexin 59 bendamustine HCl 59 ASONEP 59 Virulizin R 59 relapsed ovarian cancer 59 ponatinib 59 Clusterin 59 metastatic renal cell carcinoma 59 immune modulator 59 Aurexis 59 imatinib Gleevec 59 nucleoside 59 PARP inhibition 59 immunotherapeutic 59 CORT # 59 polysaccharide polymer 59 c MET 59 PROSTVAC ® 59 targeted antifolate 59 TREANDA 59 compound AEZS 59 p# inhibitor 59 Preclinical studies suggest 59 rxRNA 59 NS4A 59 Pertuzumab 59 HCV protease inhibitor 59 adenosine receptor 59 selective inhibitor 59 replicon 59 mitogen activated ERK kinase 59 kinase inhibitor 59 novel oral anticoagulant 59 immunomodulatory therapy 59 ALN TTR 59 ISF# 59 Velcade bortezomib 59 molecular biomarkers 59 Silodosin 59 targeting PCSK9 59 CTLA4 Ig 59 Actilon 59 non nucleoside inhibitor 59 perifosine 59 racemic baclofen 59 EndoTAG TM -1 59 enzyme inhibitors 59 small molecule defensin 59 IGF 1R 59 lorvotuzumab mertansine 59 Atiprimod 59 potent inhibitory 59 panitumumab Vectibix 59 TRAIL receptor 59 Brostallicin 59 immune modulators 59 IGF IR 59 cathepsins 59 Hedgehog Pathway Inhibitor 59 Triapine R 59 Treg cell 59 Trofex 59 N acetylgalactosamine 6 59 Canvaxin TM 59 HMG CoA reductase inhibitors 59 Epidermal Growth Factor Receptor 59 erlotinib Tarceva 59 AEGR 59 vascular disrupting 59 MVA BN 59 Muraglitazar 59 MAXY G# 59 Multimeric 59 AMPK activators 59 Kahalalide F 59 LE DT 59 NEUMUNE 59 MNTX 59 investigational monoclonal antibody 59 CD# CEA 59 BMS # 59 miR #a [002] 59 multi kinase inhibitor 59 Tumor Necrosis Factor 59 vidofludimus 59 UsiRNAs 59 endothelin receptor antagonists 59 potent inhibition 59 chimeric monoclonal antibody 59 AEZS 59 chemotherapeutic drug 59 PDGF receptor 59 Ozarelix 59 cetuximab Erbitux ® 59 cytotoxin 59 targeted radiotherapeutic 59 Chemokine Receptor 59 forodesine 59 murine models 59 Anticalins ® 59 generation antisense 59 tumorigenicity 59 nucleotide analogs 59 renin inhibitors 59 mGluR2 NAM 59 SinuNase TM 59 BNC# 59 pharmacokinetic PK 59 DEB# 59 nanoviricides 59 humanized antibody 59 peptidic 59 ADVEXIN therapy 59 adecatumumab MT# 59 taxane resistant 59 Viprovex R 59 anti neoplastic 59 torezolid phosphate 59 Apoptone 59 TRIOLEX 59 TAp# 59 CDP# 59 RNAi therapeutic targeting 59 HCV NS3 protease 59 radezolid 59 Glufosfamide 59 ATL# [001] 59 direct thrombin inhibitors 59 Aurora kinase inhibitors 59 ASG 5ME 59 Alfacell proprietary ribonuclease 59 TTR gene 59 Viprovex TM 59 K ras 59 oral picoplatin 59 GPR# agonists 59 Blinatumomab 59 Src inhibitors 59 MVA BN R 59 CDK inhibitor 59 JAK#/JAK# 59 DFMO 59 trabectedin 59 viral kinetics 59 antiangiogenesis 59 teplizumab 59 IGF 1R inhibitor 59 HDAC inhibitor 59 tumor antigen 59 PROCHYMAL 59 deforolimus 59 PEG Interferon lambda 59 BCR ABL 59 Fx #A 59 elesclomol 59 Aflibercept 59 sargramostim 59 NS#/#A protease 59 tremelimumab 59 MDV# 59 cyclophilin inhibitor 59 Genentech Rituxan 59 anti CD# antibody 59 pharmacokinetic equivalence 59 galiximab 59 trans retinoic acid 59 talactoferrin 59 SERCA2a 59 cytotoxic 59 myeloproliferative disorders 59 bafetinib 59 Pradefovir 59 novel topoisomerase 59 GSK # 59 Specifid 59 ThGRF 59 CD3 monoclonal antibody 59 CTAP# Capsules 59 NEUGENE antisense 59 resolvins 59 aleglitazar 59 Debio 59 cyclin dependent kinase inhibitor 59 RGB # 59 potent antiproliferative 59 Nektar proprietary 59 Tezampanel 59 androgen receptor AR 59 predictive biomarkers 59 mapatumumab 59 interferon γ 59 insulin sensitizing 59 triphendiol 59 ERK signaling 59 TLR9 agonists 59 estrogen receptor beta 59 rBChE 59 pediatric malignancies 59 Homspera TM 59 antidiabetic 59 paclitaxel Taxol 59 gamma secretase inhibitors 59 GFT# 59 BRAF inhibitors 59 Ambrisentan 59 PLK1 SNALP 59 MyVax 59 CCR1 58 VitiGam 58 Daclizumab 58 protease inhibitor PI 58 trastuzumab DM1 58 PDE4 inhibitors 58 HspE7 58 Hycamtin 58 Tofacitinib 58 Vidaza R 58 PTP 1B 58 cleavable linker 58 thrombin receptor 58 TNF α 58 BCX# 58 HuMax CD# 58 bendamustine 58 benzimidazole 58 thrombopoietin 58 nalbuphine ER 58 ocular formulation 58 sunitinib Sutent ® 58 dexanabinol 58 nab paclitaxel 58 alagebrium 58 nanoviricide drug 58 custirsen 58 Vaxfectin TM 58 JAK2 inhibitors 58 Intravenous CP 58 AKT inhibitor 58 antimitotic 58 milatuzumab 58 nucleoside reverse transcriptase inhibitor 58 Preclinical studies 58 insulin sensitizer 58 Prestara 58 AAG geldanamycin analog 58 Atrasentan 58 TNF inhibitor 58 BiTE 58 XP# XP# 58 HDAC inhibitors 58 LEX System 58 TRX1 58 ADVEXIN 58 TNFa 58 Palifosfamide 58 dexpramipexole 58 nilotinib Tasigna ® 58 elvitegravir 58 mimetics 58 LHRH receptor 58 Antisense 58 Menerba 58 Aurora kinase inhibitor 58 evaluating tivozanib 58 Clofarabine 58 selective estrogen receptor 58 Cloretazine R VNP#M 58 Troxatyl 58 ISTODAX 58 Sudhir Agrawal D.Phil 58 GAP #B# 58 BAL# [002] 58 R sorafenib tablets 58 incyclinide 58 immunomodulation 58 Hsp# inhibition 58 Janus kinase 58 investigational therapies 58 anti angiogenic agent 58 PEGylated interferon 58 Vitaxin 58 tumor specific antigen 58 AVI NEUGENE 58 Synavive 58 Methylnaltrexone 58 ActA 58 DACH platinum 58 Dalbavancin 58 potent antitumor activity 58 regorafenib 58 Bucindolol 58 VAPRISOL 58 peripherally acting 58 EndoTAG TM 58 GVAX ® 58 MEK inhibitor RDEA# 58 OMAPRO 58 taxane 58 dose escalation Phase 58 bevacizumab Avastin 58 visilizumab 58 micafungin 58 EndoTAG 58 Irinotecan 58 SAR# [002] 58 Apo2L 58 AVN# [001] 58 kidney urologic 58 CINOD 58 anti angiogenic drugs 58 Prodarsan ® 58 auristatin 58 KLF4 58 mTOR mammalian target 58 class mGluR5 inhibitor 58 Trabectedin 58 Cytolin R 58 Genz # 58 Bavituximab 58 TRAIL induced apoptosis 58 potent anti angiogenic 58 ANG# 58 TÎ ² 4 58 Pagoclone 58 Chrysalin 58 BiTE antibodies 58 CCR9 antagonist 58 CCR9 58 Anti Tumor 58 novel emulsion formulation 58 farletuzumab 58 EFAPROXYN 58 INGN 58 Olaparib 58 iniparib 58 atrasentan 58 NTDDS 58 tafamidis 58 myeloproliferative 58 Azedra TM 58 valopicitabine NM# 58 velafermin 58 CoFactor 58 nitric oxide donating 58 #beta HSD1 58 generation FBPase inhibitor 58 HCV NS5B polymerase 58 IMiDs R 58 Bioenvision compounds under 58 HCV replication 58 immunotherapeutic vaccine 58 Zoraxel 58 INCB# [003] 58 LymphoStat B TM 58 elvucitabine 58 Onrigin 58 MKC# PP 58 Bioaccelerate compounds under 58 Flt3 58 zanolimumab 58 AdhTAP 58 TheraCIM 58 etanercept Enbrel 58 ELND# 58 exon skipping 58 RhuDex TM 58 ADAMTS# 58 Enkephalin 58 torezolid 58 Anavex #-# 58 modulator SERM 58 PEGylated Fab fragment 58 TG# [003] 58 Guanilib 58 Cathepsin B 58 PTHrP 58 Zoraxel TM 58 IMiDs ® compound 58 vWF 58 Phase 2a clinical trials 58 Cetrorelix 58 radiolabeled TM# 58 Junovan TM 58 LibiGel ® 58 tolevamer 58 neuropilin 58 REP# 58 NOD SCID mice 58 pradefovir 58 HER2 overexpression 58 eprotirome 58 FOLOTYN ® 58 EGFr 58 Afatinib 58 efaproxiral 58 Cerashield 58 pharmacokinetic properties 58 BioVant 58 Posiphen 58 PDE# inhibitors 58 KSP inhibitor 58 Fibrillex TM 58 drug ISA# 58 Excellarate 58 recombinant antibodies